Mostrando
1
al
20
de
23
resultados
Penphomet: PEN photoporation for the genetic engineering of therapeutic mesenchymal stromal cells and T cells
TRINCE
tramitó un
HORIZON EUROPE:
Adoptive cell therapy has emerged as a promising strategy to treat cancer. It relies on patient-derived cells, such as T cells and mesenchymal stromal cells (MSCs), which are genetically engineered to...
2024-02-26 | Financiado
2024-02-26 | Financiado
COMBINE-CT: Combining CT diagnostic data and interventional approaches for futureproof cardiology care
PHILIPS MEDICAL SYSTEMS NEDERLAND BV
tramitó un
HORIZON EUROPE:
"Coronary artery disease (CAD) is caused by the pathological process in which fat, cholesterol and calcium accumulate on the arterial wall. It is the leading cause of mortality in the world, affecting...
2023-10-27 | Financiado
2023-10-27 | Financiado
RESILIENCE: Remote Ischemic Conditioning in Lymphoma Patients Receiving Anthracyclines.
CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CARLOS III FSP
tramitó un
H2020:
The increasing life expectancy of the population and the development of effective therapies result in a growing population of aged cancer survivors, which frequently have comorbidities for developing...
2021-06-01 | Financiado
2021-06-01 | Financiado
PID2021-125117OB-I00: ANALISIS DE BIOMARCADORES FARMACOGENOMICOS DE RESPUESTA AL TRATAMIENTO CON DUPILUMAB EN POLIPOSIS NASAL. POBLACIONES CELULARES IMPLICADAS Y MECANISMOS REGULADORES EPIGENETICOS
FUNDACION INSTITUTO ESTUDIOS CIENCIAS DE LA SALUD - CASTILLA Y LEON
tramitó un
AEI:
LA RINOSINUSITIS CRONICA CON POLIPOS NASALES (CRSWNP) ES UNA ENFERMEDAD INFLAMATORIA QUE AFECTA AL 4% DE LA POBLACION GENERAL. ES UNA ENFERMEDAD DE LAS VIAS RESPIRATORIAS ALTAMENTE DISCAPACITANTE CARA...
2021-01-01 | Financiado
2021-01-01 | Financiado
HARMONY PLUS: HEALTHCARE ALLIANCE FOR RESOURCEFUL MEDICINES OFFENSIVE AGAINST NEOPLASMS IN HEMATOLOGY – PLUS
FUNDACION INSTITUTO ESTUDIOS CIENCIAS DE LA SALUD - CASTILLA Y LEON
tramitó un
H2020:
Haematological malignancies (HM), also known as blood cancers, are a heterogeneous and complex group of multicausal diseases that can’t be easily diagnosed nor treated. Nowadays most treatments are ex...
2020-10-01 | Financiado
2020-10-01 | Financiado
FJC2020-045557-I: Autophagy in lymphoid leukemias
FUNDACION INSTITUTO ESTUDIOS CIENCIAS DE LA SALUD - CASTILLA Y LEON
tramitó un
AEI:
2020-01-01 | Financiado
IJC2020-044230-I: Bases Moleculares de Neurodegeneración, Neuroprotección y Reparación Cerebral
FUNDACION INSTITUTO ESTUDIOS CIENCIAS DE LA SALUD - CASTILLA Y LEON
tramitó un
AEI:
2020-01-01 | Financiado
oncNGS: NGS diagnostics in 21st century oncology: the best, for all, at all times
SCIENSANO
tramitó un
H2020:
OncNGS consortium challenges the market to research and develop novel affordable solutions to provide the best NGS tests, for all solid tumours / lymphomas patients. The challenge will consist in prov...
2020-01-01 | Financiado
2020-01-01 | Financiado
PID2019-105470RB-C32: MEJORANDO Y FOMENTANDO LA VIDA ACTIVA Y BIENESTAR DE LAS PERSONAS CON DEMENCIA Y DETERIORO COGNITIVO LEVE EN ENTORNOS RURALES
FUNDACION INSTITUTO ESTUDIOS CIENCIAS DE LA SALUD - CASTILLA Y LEON
tramitó un
AEI:
EL GRUPO DE INVESTIGACION DEL IBSAL (INSTITUTO DE INVESTIGACION BIOMEDICA DE SALAMANCA) HARA UN ESTUDIO EXPLORATORIO SOBRE LAS NECESIDADES Y OPORTUNIDADES DE LA TECNOLOGIA ASISTENCIAL Y SUS APLICACION...
2019-01-01 | Financiado
2019-01-01 | Financiado
HERMES: Hybrid Enhanced Regenerative Medicine Systems
FONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIA
tramitó un
H2020:
Brain disorders are the most invalidating condition, exceeding HIV, cancer and heart ischemia, with significant impact on society and public health. Regenerative medicine is a promising branch of heal...
2019-01-01 | Financiado
2019-01-01 | Financiado
HARMONY: Healthcare Alliance for Resourceful Medicines Offensive against Neoplasms in HematologY - Sofia ref.: 116026
FUNDACION INSTITUTO ESTUDIOS CIENCIAS DE LA SALUD - CASTILLA Y LEON
tramitó un
H2020:
Despite significant recent progress in the field of hematological malignancies (HMs), with increasing survival rates and improvement in quality of life, many children and adults with HMs still die fro...
2017-01-01 | Financiado
2017-01-01 | Financiado
EUIN2017-87355: INNOVADOR SISTEMA DE SOPORTE A LA DECISION CLINICA PARA ESTRATIFICAR A LOS PACIENTES Y PERSONALIZAR LOS TRATAMIENTOS FARMACOLOGICOS ANTIHIPERTENSIVOS Y ANALGESICOS
FUNDACION INSTITUTO ESTUDIOS CIENCIAS DE LA SALUD - CASTILLA Y LEON
tramitó un
AEI:
AKIPREV TIENE COMO OBJETIVO DESARROLLAR UN PROTOTIPO EXPERIMENTAL PARA UN SISTEMA COMPUTARIZADO DE APOYO A LA TOMA DE DECISIONES CLINICAS (SSDC) QUE AYUDARA A LOS MEDICOS A ESTRATIFICAR A LOS PACIENTE...
2017-01-01 | Financiado
2017-01-01 | Financiado
PANA: PROMOTING ACTIVE AGEING: FUNCTIONAL NANOSTRUCTURES FOR ALZHEIMER’S DISEASE AT ULTRA-EARLY STAGES.
SERVICIO GALEGO DE SAUDE SERGAS
tramitó un
H2020:
Alzheimer’s disease (AD) is the leading cause of dementia and loss of autonomy in the elderly, implying a progressive cognitive decline and limitation of social activities. Progressive aging of EU pop...
2016-03-01 | Financiado
2016-03-01 | Financiado
PTA2016-13259-I: Creación del Biobanco del Instituto Biosanitario de Salamanca (IBSAL)
FUNDACION INSTITUTO ESTUDIOS CIENCIAS DE LA SALUD - CASTILLA Y LEON
tramitó un
AEI:
2016-01-01 | Financiado
RESSTORE: REgenerative Stem cell therapy for STroke in Europe
UNIVERSITE GRENOBLE ALPES
tramitó un
H2020:
Stroke is the second leading cause of death in the world population. When not fatal, stroke often results in disability, due to motor and cognitive impairments, and secondary health problems affecting...
2015-09-01 | Financiado
2015-09-01 | Financiado
MDS-RIGHT: Providing the right care to the right patient with MyeloDysplastic Syndrome at the right time
STICHTING RADBOUD UNIVERSITEIT
tramitó un
H2020:
Myelodysplastic syndromes (MDS) are chronic bone marrow malignancies of the elderly, complicated by severe anaemia. MDS significantly affects quality-adjusted survival and it imposes an increasing fin...
2015-05-01 | Financiado
2015-05-01 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.
Tecnologías
#Sin Completar
Datos compañía
CNAE
8559 - Otra educación n.c.o.p..
Empleados
141 Empleados.
Dirección
(CASTILLA Y LEÓN)
.
NIF
G42152405
Objeto Social
N.D.